Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × cabozantinib × Clear all

NCT01716715 2020-03-10

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Phase 2 Completed

111 enrolled 13 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02315430 2020-03-10

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

13 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms